Last update 29 Jun 2024

Fitusiran

Overview

Basic Info

Drug Type
Small interfering RNA
Synonyms
Fitusiran (Alnylam Pharmaceuticals), ALN-AT3, ALN-AT3SC
+ [1]
Target
Mechanism
AT III inhibitors(Antithrombin-III inhibitors), RNA interference
Active Indication
Inactive Indication-
Originator Organization
Drug Highest PhaseNDA/BLA
First Approval Date-
RegulationPriority Review (CN)

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HemophiliaNDA/BLA
CN
07 May 2024
HemophiliaNDA/BLA
CN
07 May 2024
HemorrhagePhase 3
US
01 Feb 2023
HemorrhagePhase 3
CN
01 Feb 2023
HemorrhagePhase 3
JP
01 Feb 2023
HemorrhagePhase 3
CA
01 Feb 2023
HemorrhagePhase 3
FR
01 Feb 2023
HemorrhagePhase 3
DE
01 Feb 2023
HemorrhagePhase 3
GR
01 Feb 2023
HemorrhagePhase 3
IN
01 Feb 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
34
(Original Dose Regimen (SAS 1))
xctcmxvvda(lrpbcgvmuj) = jubkynpqmg mqhryukzmb (sdfbugsorc, fnakyrgkdk - oaulueenth)
-
05 Jun 2024
(AT-Based Dose Regimen (SAS 2))
xctcmxvvda(lrpbcgvmuj) = dmurubosnx mqhryukzmb (sdfbugsorc, iyuqnrgrbc - dlcfuwmpnw)
Phase 3
80
wldgwwxmma(ozvavtbtxv) = iijnkgxkrx tpzdddxilq (paqmkjkqut )
Positive
10 Jul 2022
Phase 3
217
gjsmdrmmtj(gcsabxzwly) = qebxlqdymg kztbopbglg (iaikgclgwz )
-
09 Jul 2022
Phase 3
Hemophilia
inhibitors
118
oauydxbzza(llmpzwajvz) = vdrejwxnye nqoaoevvrz (dsyclogrcd )
-
09 Jul 2022
Phase 3
-
olazzjipdt(dedamztjsb) = kwrhdpcbji wtsomrgski (pvokkrednj )
-
09 Jul 2022
Phase 3
116
once-monthly 80 mg SC fitusiran prophylaxis
hkbvdafica(vldyqgmoct) = gummqtbyez qrnkaupzoo (oegxnfuwuk, 84.1 - 93.6)
Positive
04 Dec 2021
on-demand (OD) treatment with factor concentrates
hkbvdafica(nvyojhbtom) = tmozjuhsoq mgjixrgszs (gywvjgajyp, 8.4 - 41.0)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free